An early pilot trial suggests that combining atezolizumab (tecectriq) with rituximab (Rituxan), gemcitabine (gemzar) and ...

The Pullman Fire Department recently participated in a stair climb fundraiser organized by the Leukemia and Lymphoma Society.

Dr. Deepa Jagadeesh discusses Ordspono's potential FDA approval for relapsed/refractory follicular lymphoma, highlighting its manageable toxicity and low CRS rate.

EC approves BMY's Breyanzi for relapsed or refractory FL, based on Phase 2 study showing high response rates & sustained ...

The Scotia-Glenville Central School District says their team, “Rays of Hope,” is committed to the Leukemia and Lymphoma ...

In a real-world study, researchers found this data by comparing treatment patterns, healthcare resource utilization, and ...

Investing.com -- The European Commission has granted Bristol Myers (NYSE: BMY) Squibb, the biopharmaceutical company based in ...

Researchers found that GLP-1 receptor agonists (GLP-1RAs) significantly reduce the risk of several blood cancers in type 2 ...

Nikki Gooding, a nurse practitioner, said she had been using an Oura ring -- a smart ring that tracks a person's health ...

Roughly two months after learning he was living with cancer, the president of the Harry Caray Restaurant Group on Friday made a stunning announcement: he’s in remission.

SUV remains the most widely used PET parameter to evaluate NHLs because it is directly associated with lymphoma aggressiveness.

Scientists from the University of Southern Denmark (SDU) and the University of Helsinki have now found a potential link ...